CTEC.L vs OPCH
CTEC.L: Convatec is a specialist medical technology company providing life-improving solutions for wound, ostomy, continence, and infusion care. OPCH: Option Care Health is a national leader in home and alternate site infusion services, providing essential, complex clinical care to patients outside of hospital settings.
Side-by-side fundamentals
| Metric | CTEC.L | OPCH | Edge |
|---|---|---|---|
| Price as of 2026-08-03 close | £2.25 | $23.70 | |
| Market cap as of 2026-08-06 | n/a | $3.7B | |
| P/E as of 2026-08-06 | n/a | 16.87 | |
| PEG as of 2026-08-06 | n/a | 1.66 | |
| Net margin as of 2026-08-06 | n/a | +3.7% | |
| Gross margin as of 2026-08-06 | n/a | +19.1% | |
| Operating margin as of 2026-08-06 | n/a | +5.9% | |
| ROE as of 2026-08-06 | n/a | +15.8% | |
| ROA as of 2026-08-06 | n/a | +6.1% | |
| Debt / equity as of 2026-08-06 | n/a | 0.92 | |
| Revenue growth (YoY) as of 2026-08-06 | n/a | +6.0% | |
| Revenue CAGR (3y) SEC XBRL | n/a | +13.4% | |
| Beta as of 2026-08-06 | n/a | 0.57 | |
| 1-year return as of 2026-08-03 close | -2.4% | -15.7% | CTEC.L higher |
Fundamentals: market data, as of 2026-08-06. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-03.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.